AML bloodcancer
Conditions
Interventions
None listed
Sponsors
Medisch Centrum Leeuwarden
Eligibility
Age
65 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients in the Dutch province of Friesland may present at any of the 4 Frisian Hospitals. Complicated cases such as elderly patients with AML are referred to the MCL. Patients from outside of the province of Friesland are uncommon.
Exclusion criteria
Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: • Age upon diagnosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| • Quality of Life reported by patient • Overall survival | — |
Secondary
| Measure | Time frame |
|---|---|
| • Rate of Complete Remission or Complete Remission with incomplete count recovery CR/CRi • Early Death (30-day mortality) • Ferrara Criteria treatment advice • Wheatley Score • HCT-CI Score • AML-CM Score • ECOG Performance Status • Cytogenetica / molecular risk profile • ELN classification • Other parameters necessary for scoring such as eGFR, LDH, RBC, BMI, Albumine, Serum Creatinine • Treatment regimen as per 2 weeks after diagnosis • Healthcare usage such as antibiotic prescription events or receiving blood transfusion • Quality of Life as reported posthumous by relatives A complete list of datapoints collected and how they will be formatted in our research database can be found in the excel file *Databasestructure ZEALOUS-AML*. | — |
Countries
Netherlands
Outcome results
None listed